Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. A. Buchholz
The Nuclear Transcription Factor B/BCL-2 Pathway Correlates With Pathologic Complete Response to Doxorubicin-Based Neoadjuvant Chemotherapy in Human Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Phase I/Ii Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination With Doxorubicin and Docetaxel in Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Genome-Wide DNA Methylation Signatures to Predict Pathologic Complete Response From Combined Neoadjuvant Chemotherapy With Bevacizumab in Breast Cancer
PLoS ONE
Multidisciplinary
Hormone Receptor-Negative as a Predictive Factor for Pathologic Complete Response to Neoadjuvant Therapy in Breast Cancer
Einstein (São Paulo, Brazil)
Medicine
P53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
RB-Pathway Disruption Is Associated With Improved Response to Neoadjuvant Chemotherapy in Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative1H MR Spectroscopy
Radiology
Nuclear Medicine
Radiology
Imaging
Accuracy of Ultrasonography and Mammography in Predicting Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
American Journal of Surgery
Medicine
Surgery
Pathologic Tumor Response to Neoadjuvant Chemotherapy in Gastroesophageal Cancer: What Does It Mean?
Translational Gastroenterology and Hepatology
Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Journal of Medical – Clinical Research & Reviews
